Bioelectronics Corp
BioElectronics Corporation, an electroceutical company, engages in the development and sale of wearable, neuromodulation devices to mitigate neurological diseases and enhance quality of life worldwide. Its products include ActiPatch, a musculoskeletal pain therapy; Allay, a menstrual pain therapy; and Smart Insole, a heel pain therapy. The company also offers RecoveryRx, a medical device that pro… Read more
Market Cap & Net Worth: Bioelectronics Corp (BIEL)
Bioelectronics Corp (PINK:BIEL) has a market capitalization of $7.41 Million ($7.41 Million) as of March 19, 2026. Listed on the PINK stock exchange, this USA-based company holds position #50921 globally and #15644 in its home market, demonstrating a 50.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Bioelectronics Corp's stock price $0.00 by its total outstanding shares 24705066971 (24.71 Billion).
Bioelectronics Corp Market Cap History: 2015 to 2025
Bioelectronics Corp's market capitalization history from 2015 to 2025. Data shows change from $27.18 Million to $7.41 Million (-10.96% CAGR).
Bioelectronics Corp Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Bioelectronics Corp's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
14.94x
Bioelectronics Corp's market cap is 14.94 times its annual revenue
0.67x
Higher than industry averageLatest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2015 | $27.18 Million | $2.34 Million | -$2.45 Million | 11.62x | N/A |
| 2016 | $7.41 Million | $2.09 Million | -$2.11 Million | 3.55x | N/A |
| 2017 | $17.29 Million | $1.76 Million | -$2.12 Million | 9.80x | N/A |
| 2018 | $14.82 Million | $1.05 Million | -$2.99 Million | 14.17x | N/A |
| 2019 | $19.76 Million | $941.76K | -$2.33 Million | 20.99x | N/A |
| 2020 | $32.12 Million | $829.56K | -$1.16 Million | 38.72x | N/A |
| 2021 | $24.71 Million | $1.61 Million | -$289.82K | 15.35x | N/A |
| 2022 | $12.35 Million | $707.41K | -$784.91K | 17.46x | N/A |
| 2023 | $4.94 Million | $714.71K | -$722.81K | 6.91x | N/A |
| 2024 | $7.41 Million | $496.03K | -$930.65K | 14.94x | N/A |
Competitor Companies of BIEL by Market Capitalization
Companies near Bioelectronics Corp in the global market cap rankings as of March 19, 2026.
Key companies related to Bioelectronics Corp by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #84 globally with a market cap of $187.53 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #151 globally with a market cap of $119.88 Billion USD.
- Medtronic PLC (NYSE:MDT): Ranked #170 globally with a market cap of $111.60 Billion USD.
- Boston Scientific Corp (NYSE:BSX): Ranked #183 globally with a market cap of $105.38 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #84 | Abbott Laboratories | NYSE:ABT | $187.53 Billion | $108.49 |
| #151 | Stryker Corporation | NYSE:SYK | $119.88 Billion | $345.81 |
| #170 | Medtronic PLC | NYSE:MDT | $111.60 Billion | $87.21 |
| #183 | Boston Scientific Corp | NYSE:BSX | $105.38 Billion | $71.28 |
Bioelectronics Corp Historical Marketcap From 2015 to 2025
Between 2015 and today, Bioelectronics Corp's market cap moved from $27.18 Million to $ 7.41 Million, with a yearly change of -10.96%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | $7.41 Million | 0.00% |
| 2024 | $7.41 Million | +50.00% |
| 2023 | $4.94 Million | -60.00% |
| 2022 | $12.35 Million | -50.00% |
| 2021 | $24.71 Million | -23.08% |
| 2020 | $32.12 Million | +62.50% |
| 2019 | $19.76 Million | +33.33% |
| 2018 | $14.82 Million | -14.29% |
| 2017 | $17.29 Million | +133.33% |
| 2016 | $7.41 Million | -72.73% |
| 2015 | $27.18 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 19th, 2026 the market cap of Bioelectronics Corp was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $7.41 Million USD |
| MoneyControl | $7.41 Million USD |
| MarketWatch | $7.41 Million USD |
| marketcap.company | $7.41 Million USD |
| Reuters | $7.41 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.